Landmark Cannabis and Pregnancy Study Faces Silence as Women Face Punitive Policies
Despite decades-old research showing no harm from prenatal cannabis exposure, pregnant women still face legal penalties and stigma as new studies reinforce the need for evidence-based policy
Key Points
- 1Melanie Dreher’s 1994 study found babies exposed to cannabis in utero showed positive developmental outcomes
- 2Institutional and political resistance has blocked further research funding, despite scientific merit
- 3Recent large-scale studies confirm no negative cognitive effects from prenatal cannabis exposure after accounting for sociodemographic factors
- 4Pregnant women in the U.S. continue to face legal penalties and child separation related to cannabis use
In 1994, Melanie Dreher's groundbreaking research challenged the prevailing belief that cannabis use during pregnancy is inherently harmful, revealing that babies exposed to cannabis in utero thrived in key developmental areas. Despite the study’s rigor and striking results, the medical establishment largely ignored the findings, and Dreher encountered institutional resistance instead of engagement. As cannabis laws liberalize globally, the stigma and punitive measures targeting pregnant women who use cannabis persist, with some mothers still facing jail or forced separation from their newborns
Dreher’s journey into cannabis research began unexpectedly when she joined a federally funded study in Jamaica in the late 1960s, where cannabis was integrated into daily life as medicine and nourishment. Observing local customs, she witnessed mothers using cannabis tea to ease morning sickness and support child health, leading her to propose a formal study on cannabis use during pregnancy. Collaborating with Harvard-affiliated pediatrician Kevin Nugent, Dreher’s team conducted systematic assessments of babies born to cannabis-using mothers, finding that "the babies with the most cannabis exposure did the best," according to Dreher
Despite the compelling data, follow-up funding and institutional support never materialized. Dreher recounted how NIH proposals for further research were derailed after U.S. legislators objected to positive depictions of cannabis-using mothers and healthy children. “The lawmakers went nuts,” Dreher said, explaining that the political climate stifled scientific inquiry and left her to seek private funding for a new study. She has personally contributed $25,000, estimating that $100,000 could fund a meaningful follow-up, yet federal backing remains elusive
The original Jamaican study, later expanded by anthropologist Rebekah Hudgins, followed children through age five and found no negative effects from prenatal cannabis exposure on motor skills, behavior, or cognitive development. Hudgins noted, “The Jamaican study is the only study of its kind with a predominantly single drug-use population that collected extensive ethnographic data and standardized testing data and found no detrimental effects even within the highest consumption households.” Dr. Genester Wilson-King, a board-certified obstetrician and gynecologist, continues to advocate for evidence-based cannabis policies, having testified in court to support women facing charges related to cannabis use during pregnancy
Recent research continues to align with Dreher’s early findings. A 2026 study published in Alcohol: Clinical & Experimental Research, which tracked over 11,000 adolescents, concluded that prenatal cannabis exposure did not negatively impact cognitive development once sociodemographic factors were considered. For the cannabis industry and public health policymakers, these findings highlight the urgent need for unbiased, comprehensive research and a reevaluation of punitive policies targeting pregnant women. From the OG Lab newsroom perspective, this ongoing silence from the scientific and regulatory community underscores the critical role of evidence-based policy and the necessity of supporting research that addresses stigma, not just science, in cannabis and maternal health
